Summary
Chronic leg ulceration is a very common clinical problem in the elderly. Good management depends entirely on making an accurate diagnosis, and planning treatment after considering all aspects of patient well-being. All elderly patients with leg ulcers benefit from an assessment of their vascular status, since the effects of gravity influence treatment and healing irrespective of the diagnosis.
The most common causes of ulceration are venous and arterial disease. Diabetes mellitus, pressure, vasculitis, metabolic abnormalities and skin cancer are all unusual causes of leg ulceration, but must be considered in the differential diagnosis. Almost all patients with ulcerated legs benefit from the use of compression bandaging at a level appropriate to their vascular status. In patients with venous ulcers, this can be achieved with a number of bandaging techniques; however, multilayer bandaging appears to be the most cost-effective means available, particularly when combined with community-based leg ulcer clinics.
The effects of oral drug therapy for venous and arterial disease have been disappointing. Local dressings are important in ulcers that are not suitable for compression therapy. The choice of dressing depends on the nature of the ulcer and the tolerability of the dressing for the patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Freak L, Simon D, Kinsella A, et al. Leg ulcer care: an audit of cost effectiveness. Health Trends 1995; 27: 133–6
Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: the extent of the problem and the provision of care. BMJ 1985; 290: 1855–6
Hallbook T, Lanner E. Serum zinc and healing of venous leg ulcers. Lancet 1972; II: 780–2
Wilson CL, Cameron J, Powell S, et al. High incidence of contact sensitivity in leg ulcer patients — implications for management. Clin Exp Dermatol 1991; 16: 259–63
Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969; 56: 676–9
Moffat CJ, Dorman MC. Recurrence of leg ulcers within a community ulcer service. J Wound Care 1995; 4: 57–61
Taylor G, Goodfield MJD, O’Neill S. Pain associated with venous leg ulceration [abstract]. Br J Dermatol 1995; 133Suppl. 45: 33
Ryan TJ, Burnand K. Diseases of the veins and arteries — leg ulcers. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. 5th ed. Oxford: Blackwell Scientific Publications, 1992: 1963–2013
Salim AS. The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: a new approach. World J Surg 1991; 15: 264–9
Blair SD, Wright DDI, Backhouse CM, et al. Sustained compression and healing of chronic venous ulcers. BMJ 1988; 297: 1159–61
Moffat CJ, Franks PJ, Oldroyd M, et al. Community clinics for leg ulcers and impact on healing. BMJ 1992; 78: 1269–70
Thomson B, Hooper P, Powell R, et al. Four layer bandaging and healing rates of venous leg ulcers. J Wound Care 1996; 5: 213–6
Simon DA, Freak L, Kinsella A, et al. Community leg ulcer clinics: a comparative study in two health authorities. BMJ 1996; 312: 1648–51
Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous ulcers. J Am Acad Dermatol 1986; 15: 186–91
Blair SD, Backhouse CM, Wright DDI, et al. Do dressings influence the healing of chronic venous ulcers? A randomized clinical trial. Phlebology 1988; 3: 129–34
Lineweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985; 120: 267–70
De Luca M, Albanese E, Cancedda R, et al. Treatment of leg ulcers with cryopreserved allogenic cultured epithelium: a multicentre study. Arch Dermatol 1992; 128: 633–8
Falanga V, Eaglestein WH, Bucalo B, et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992; 18: 604–6
Ibbotson SH, Layton AM, Davies JA, et al. Randomised trial of oral aspirin for chronic venous leg ulcers. Lancet 1994; 344: 1513–4
Layer GT, Stacey MC, Burnand KG. Stanozolol and the treatment of venous ulceration — an interim report. Phlebology 1986; 1: 197–203
Colgan MP, Dormandy JA, Jones PW, et al. Oxypentifylline treatment of venous ulcers of the leg. BMJ 1090; 300: 972–5
Guilhou J-J, Dereure O, Marzin L, et al. Efficacy of daflon 500mg in venous leg ulcer healing: a double blind, randomised, controlled versus placebo trial in 107 patients. Angiology 1997; 48: 77–85
Sanlaska CP, Winfield GA. Pentoxifylline. J Am Acad Dermatol 1994; 30: 60–71
Wernerschlenzka H, Lehnert W. Topical treatment of venous legulcers with a prostacyclin hydrogel: a double blind trial. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 203–6
Alberdi JMZ. Hypertensive ulcers: Martorell’s ulcer. Phlebology 1988; 3: 139–42
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goodfield, M. Optimal Management of Chronic Leg Ulcers in the Elderly. Drugs & Aging 10, 341–348 (1997). https://doi.org/10.2165/00002512-199710050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199710050-00003